Price Of Critical SMA Drug May Fall By 90% With Natco’s Generic Launch
Parents of children with spinal muscular atrophy (SMA) have welcomed Indian pharmaceutical company Natco's announcement.
Study Links Spinal Muscular Atrophy To Increased Risk Of Fatty Liver Disease
An international study from researchers found a concerning link between Spinal Muscular Atrophy and an increased risk of fatty liver disease.
